The trademark application SQZ was filed by SQZ Biotechnologies Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on March 23, 2021, and it was registered by office on June 30, 2021 without any oppositions.
The application was filed in English (Italian was selected as the second language).
Change of name and address of the trademark registration was recorded on April 28, 2021.
Goods And Services
The mark was filed in class 5 with Pharmaceuticals for the treatment of medical conditions, namely, for modifying the immune response to treat cancer, autoimmune diseases, infectious diseases, and regenerative diseases for medical purposes, for modifying cells to treat rare diseases, cancer, autoimmune diseases, infectious diseases, and regenerative diseases for medical purposes and cells for medical use, namely cells for use in creating cell and gene therapies for the treatment of medical conditions..
The mark was filed in class 9 with following description of goods:
Biochips for scientific research purposes, including for delivery of macromolecules to cells
Kit comprising a control system, biochips, a holder set, and a pressurized gas system for scientific research purposes
Kits comprising a control system, biochips, a holder set, and a pressurized gas system for delivery of macromolecules to cells for scientific research purposes.
The mark was filed in class 10 with following description of goods:
Biochips for medical purposes including cell therapy and immunotherapy
Biochips for delivery of macromolecules and molecules to cells for medical purposes
Kit comprising a control system, biochips, a holder set, and a pressurized gas system for medical purposes
Kit comprising a control system, biochips, a holder set, and a pressurized gas system for delivery of macromolecules to cells for medical purposes
Kit comprising a control system, biochips and disposable tubing and containers for the creation of cell therapies for medical purposes
Medical device apparatus containing the kit comprising a control system, biochips and associated containers and connectors and specially adapted for the creation of cell therapies for medical purposes.
The mark was filed in class 44 with Cell and gene therapies for the treatment of medical conditions for medical purposes, namely, cancer, rare diseases, autoimmune diseases, regenerative diseases and infectious diseases.